113 related articles for article (PubMed ID: 15548703)
21. Ras effector pathways modulate scatter factor-stimulated NF-kappaB signaling and protection against DNA damage.
Fan S; Meng Q; Laterra JJ; Rosen EM
Oncogene; 2007 Jul; 26(33):4774-96. PubMed ID: 17297451
[TBL] [Abstract][Full Text] [Related]
22. Growth inhibition of multiple myeloma cells by a novel IkappaB kinase inhibitor.
Sanda T; Iida S; Ogura H; Asamitsu K; Murata T; Bacon KB; Ueda R; Okamoto T
Clin Cancer Res; 2005 Mar; 11(5):1974-82. PubMed ID: 15756023
[TBL] [Abstract][Full Text] [Related]
23. Distinct nuclear factor-kappaB/Rel proteins have opposing modulatory effects in glutamate-induced cell death in HT22 cells.
Ishige K; Tanaka M; Arakawa M; Saito H; Ito Y
Neurochem Int; 2005 Dec; 47(8):545-55. PubMed ID: 16183169
[TBL] [Abstract][Full Text] [Related]
24. Pim-1 kinase as activator of the cell cycle pathway in neuronal death induced by DNA damage.
Zhang Y; Parsanejad M; Huang E; Qu D; Aleyasin H; Rousseaux MW; Gonzalez YR; Cregan SP; Slack RS; Park DS
J Neurochem; 2010 Jan; 112(2):497-510. PubMed ID: 19895669
[TBL] [Abstract][Full Text] [Related]
25. The mouse RACK1 gene is regulated by nuclear factor-kappa B and contributes to cell survival.
Choi DS; Young H; McMahon T; Wang D; Messing RO
Mol Pharmacol; 2003 Dec; 64(6):1541-8. PubMed ID: 14645685
[TBL] [Abstract][Full Text] [Related]
26. Pim-1: a serine/threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesis.
Wang Z; Bhattacharya N; Weaver M; Petersen K; Meyer M; Gapter L; Magnuson NS
J Vet Sci; 2001 Dec; 2(3):167-79. PubMed ID: 12441685
[TBL] [Abstract][Full Text] [Related]
27. Expression of PIM-2 and NF-κB genes is increased in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) and is associated with complete remission rate and overall survival.
Kapelko-Słowik K; Urbaniak-Kujda D; Wołowiec D; Jaźwiec B; Dybko J; Jakubaszko J; Słowik M; Kuliczkowski K
Postepy Hig Med Dosw (Online); 2013 Jun; 67():553-9. PubMed ID: 23752607
[TBL] [Abstract][Full Text] [Related]
28. Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-myc.
Allen JD; Verhoeven E; Domen J; van der Valk M; Berns A
Oncogene; 1997 Sep; 15(10):1133-41. PubMed ID: 9294606
[TBL] [Abstract][Full Text] [Related]
29. The serine/threonine kinase Pim-2 is a novel anti-apoptotic mediator in myeloma cells.
Asano J; Nakano A; Oda A; Amou H; Hiasa M; Takeuchi K; Miki H; Nakamura S; Harada T; Fujii S; Kagawa K; Endo I; Yata K; Sakai A; Ozaki S; Matsumoto T; Abe M
Leukemia; 2011 Jul; 25(7):1182-8. PubMed ID: 21475253
[TBL] [Abstract][Full Text] [Related]
30. The Pim kinases control rapamycin-resistant T cell survival and activation.
Fox CJ; Hammerman PS; Thompson CB
J Exp Med; 2005 Jan; 201(2):259-66. PubMed ID: 15642745
[TBL] [Abstract][Full Text] [Related]
31. Expression and significance of Pim-3 kinase in adult T-cell leukemia.
Ishikawa C; Senba M; Hashimoto T; Imaizumi A; Mori N
Eur J Haematol; 2017 Dec; 99(6):495-504. PubMed ID: 28833639
[TBL] [Abstract][Full Text] [Related]
32. Roles of Pim-3, a novel survival kinase, in tumorigenesis.
Mukaida N; Wang YY; Li YY
Cancer Sci; 2011 Aug; 102(8):1437-42. PubMed ID: 21518143
[TBL] [Abstract][Full Text] [Related]
33. Pim-2 activates API-5 to inhibit the apoptosis of hepatocellular carcinoma cells through NF-kappaB pathway.
Ren K; Zhang W; Shi Y; Gong J
Pathol Oncol Res; 2010 Jun; 16(2):229-37. PubMed ID: 19821157
[TBL] [Abstract][Full Text] [Related]
34. The role of NF-kappaB in lymphoid malignancies.
Packham G
Br J Haematol; 2008 Oct; 143(1):3-15. PubMed ID: 18573107
[TBL] [Abstract][Full Text] [Related]
35. Pim kinase-dependent inhibition of c-Myc degradation.
Zhang Y; Wang Z; Li X; Magnuson NS
Oncogene; 2008 Aug; 27(35):4809-19. PubMed ID: 18438430
[TBL] [Abstract][Full Text] [Related]
36. The effects of benzene and the metabolites phenol and catechol on c-Myb and Pim-1 signaling in HD3 cells.
Wan J; Winn LM
Toxicol Appl Pharmacol; 2004 Dec; 201(2):194-201. PubMed ID: 15541759
[TBL] [Abstract][Full Text] [Related]
37. CD40 signaling in B cells regulates the expression of the Pim-1 kinase via the NF-kappa B pathway.
Zhu N; Ramirez LM; Lee RL; Magnuson NS; Bishop GA; Gold MR
J Immunol; 2002 Jan; 168(2):744-54. PubMed ID: 11777968
[TBL] [Abstract][Full Text] [Related]
38. PIM Kinases Promote Survival and Immune Escape in Primary Mediastinal Large B-Cell Lymphoma through Modulation of JAK-STAT and NF-κB Activity.
Szydłowski M; Dębek S; Prochorec-Sobieszek M; Szołkowska M; Tomirotti AM; Juszczyński P; Szumera-Ciećkiewicz A
Am J Pathol; 2021 Mar; 191(3):567-574. PubMed ID: 33307035
[TBL] [Abstract][Full Text] [Related]
39. Cutting edge: Transcriptional activity of NFATc1 is enhanced by the Pim-1 kinase.
Rainio EM; Sandholm J; Koskinen PJ
J Immunol; 2002 Feb; 168(4):1524-7. PubMed ID: 11823475
[TBL] [Abstract][Full Text] [Related]
40. Constitutive activation of NF-kappaB and T-cell leukemia/lymphoma in Notch3 transgenic mice.
Bellavia D; Campese AF; Alesse E; Vacca A; Felli MP; Balestri A; Stoppacciaro A; Tiveron C; Tatangelo L; Giovarelli M; Gaetano C; Ruco L; Hoffman ES; Hayday AC; Lendahl U; Frati L; Gulino A; Screpanti I
EMBO J; 2000 Jul; 19(13):3337-48. PubMed ID: 10880446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
